Natural Killer Cell Activity Is Increased in Chronic Active Antibody-Mediated Rejection (caABMR) of Human Kidney Allografts

被引:0
|
作者
Rahim, Shab E. Gul [1 ]
Varma, Elly [1 ]
Salinas, Thalia [1 ]
Li, Carol Y. [1 ]
Snopkowski, Catherine [1 ]
Salvatore, Steven [1 ]
Seshan, Surya V. [1 ]
Dadhania, Darshana M. [1 ]
Suthanthiran, Manikkam [1 ]
Muthukumar, Thangamani [1 ]
机构
[1] Weill Cornell Med, New York, NY USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
FR-PO767
引用
收藏
页码:532 / 532
页数:1
相关论文
共 50 条
  • [31] Proposed Diagnostic Criteria for Chronic Antibody-Mediated Rejection in Liver Allografts
    O'Leary, J. G.
    Cai, J.
    Freeman, R.
    Banuelos, N.
    Hart, B.
    Johnson, M.
    Jennings, L. W.
    Kaneku, H.
    Terasaki, P. I.
    Klintmalm, G. B.
    Demetris, A. J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (02) : 603 - 614
  • [32] Linking donor-specific antibody generation with natural killer cells in antibody-mediated kidney graft rejection
    Perkins, Griffith B.
    Fairchild, Robert L.
    [J]. KIDNEY INTERNATIONAL, 2023, 104 (04) : 644 - 646
  • [33] Rationale for the IMAGINE study for chronic active antibody-mediated rejection (caAMR) in kidney transplantation
    Nickerson, Peter W. W.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 38 - 44
  • [34] Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation
    Muller, Yannick D.
    Ghaleb, Nseir
    Rotman, Samuel
    Vionnet, Julien
    Halfon, Matthieu
    Catana, Emmanuelle
    Golshayan, Dela
    Venetz, Jean-Pierre
    Aubert, Vincent
    Pascual, Manuel
    [J]. TRANSPLANT INTERNATIONAL, 2018, 31 (04) : 451 - 455
  • [35] RITUXIMAB AS MONOTHERAPY FOR THE TREATMENT OF CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION
    Muller, Yannick
    Ghaleb, Nseir
    Rotman, Samuel
    Catana, Emmanuelle
    Golshayan, Dela
    Venetz, Jean-Pierre
    Aubert, Vincent
    Pascual, Manuel
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 553 - 554
  • [36] Increased risk of antibody-mediated rejection of reduced-size liver allografts
    Astarcioglu, I
    Cursio, R
    Reynes, M
    Gugenheim, J
    [J]. JOURNAL OF SURGICAL RESEARCH, 1999, 87 (02) : 258 - 262
  • [37] Antibody-mediated Vascular Rejection of Kidney Allografts: A Population-based Study
    Nguan, Christopher
    [J]. UROLOGY, 2013, 82 (03) : 503 - 504
  • [38] Microvascular Inflammation in Early Protocol Biopsies of Renal Allografts in Cases of Chronic Active Antibody-Mediated Rejection
    Tsuji, T.
    Yanai, M.
    Itami, H.
    Ishii, Y.
    Akimoto, M.
    Fukuzawa, N.
    Harada, H.
    Fukasawa, Y.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [39] Microvascular inflammation in early protocol biopsies of renal allografts in cases of chronic active antibody-mediated rejection
    Tsuji, Takahiro
    Yanai, Mitsuru
    Itami, Hiroe
    Ishii, Yasushi
    Akimoto, Mayuko
    Fukuzawa, Nobuyuki
    Harada, Hiroshi
    Fukasawa, Yuichiro
    [J]. NEPHROLOGY, 2015, 20 : 26 - 30
  • [40] IMPACT OF ANTIBODY-MEDIATED VASCULAR REJECTION ON KIDNEY ALLOGRAFTS: HOW IMPORTANT IS PTC?
    Cubillo, Beatriz
    Calvo, Natividad
    Calvo, Marta
    Angeles Moreno, Maria
    Perez Flores, Isabel
    Pascual, Alejandro
    Isabel Sanchez-Fructuoso, Ana
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 76 - 77